mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
0.19 |
0.001 |
mRNA |
PD-0325901 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.16 |
0.002 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.002 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.002 |
mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.003 |
mRNA |
BRD-K33199242 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.003 |